Home > Riviste > Minerva Medica > Fascicoli precedenti > Articles online first > Minerva Medica 2021 May 14

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Medica 2021 May 14

DOI: 10.23736/S0026-4806.21.07497-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Management of Lemierre syndrome

Luca VALERIO 1 , William PLEMING 2, Alessandro PECCI 3, Stefano BARCO 2

1 Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany; 2 Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland; 3 Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy


PDF


Lemierre syndrome is a rare form of septic thrombophlebitis of the head and neck veins, most typically the internal jugular vein, which affects otherwise healthy adolescents and young adults after an oropharyngitis or other local infection and is characterized by multiple septic embolization. Despite treatment, Lemierre syndrome displays a high rate of in-hospital complications that include thrombus progression and new peripheral septic embolization, and it can be fatal or cause disabling sequelae. The mainstay of treatment is antibiotic therapy; anticoagulation is often used, but its role is controversial. Surgical treatment is often necessary in case of peripheral septic lesions. In the absence of prospective studies, what little guidance exists on its management is based on case series or on analogy with similar conditions such as other forms of septic thrombophlebitis or non-septic venous thrombosis. Over the last few years, new observational evidence has improved our knowledge of the clinical epidemiology of this condition and highlighted a number of promising management strategies. We provide an overview of the treatment patterns observed in the contemporary era, summarise the arguments proposed so far against or in favour of alternative treatments as well as possible decision rules on the use of anticoagulation, and outline the priorities of ongoing and future observational and interventional research.


KEY WORDS: Lemierre syndrome; Septic thrombophlebitis; Venous thromboembolism; Fusobacterium; Infectious disease; Oropharyngitis; Paediatric thrombosis; Anticoagulation

inizio pagina